<DOC>
	<DOCNO>NCT02639299</DOCNO>
	<brief_summary>Background : Malaria serious infection cause parasite . People get malaria infect mosquito bite . Malaria cause major health social problem place malaria common , Africa also affect traveler never expose malaria . Researchers NIH want find safe effective malaria vaccine , antimalarial drug , prevention regimen . To , healthy volunteer recruit general screening study order see qualify join future malaria study . Objective : To screen healthy volunteer see eligible join investigational malaria study . The study trials investigational antimalarial drug , malaria vaccine , prevention regimen . They may also involve control human malaria infection trial . Eligibility : Healthy people age 18 50 Design : Participants first prescreened phone . Participants screen : Medical history Physical exam Blood urine test Participants may go 1 year without join clinical trial . If happens , may re-contacted see still want part screen protocol . Those still want participate relevant medical change rescreened .</brief_summary>
	<brief_title>Screening Healthy Volunteers Investigational Antimalarial Drugs , Malaria Vaccines , Controlled Human Malaria Challenge</brief_title>
	<detailed_description>This screen protocol healthy volunteer participate research study conduct Laboratory Malaria Immunology Vaccinology ( LMIV ) . Malaria-related morbidity mortality major economic impact endemic region present substantial health risk non-immune traveler people live endemic area . To stem worldwide impact devastate disease , safe broadly effective malaria vaccine improve antimalarial therapeutic urgently require . This screening protocol design continuously evaluate potential healthy volunteer build pool volunteer may participate future ongoing LMIV malaria drug , vaccine , control human malaria infection ( CHMI ) trial . A complete medical history blood urine sample obtain evaluate whether volunteer eligible study-specific screening .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Antimalarials</mesh_term>
	<criteria>INCLUSION CRITERIA : All follow criterion must fulfil subject participate trial : 1 . Age great equal 18 less equal 50 year . 2 . In good general health without clinically significant medical history 3 . Reliable access clinical trial center available area 1 year 4 . Females childbearing potential must willing undergo periodic pregnancy test use reliable contraception per protocol enrol LMIV clinical trial ( protocolspecific requirement ) EXCLUSION CRITERIA : A subject exclude participate trial one follow criterion fulfil : 1 . Pregnant , breastfeeding , plan pregnancy upcoming year . 2 . Hemoglobin , white blood cell ( WBC ) , platelet , alanine transaminase ( ALT ) , creatinine ( Cr ) outside local lab normal range ( subject may include investigator discretion clinically significant value outside normal range ) . 3 . Abnormal urinalysis define positive urine glucose , protein , hemoglobin . Subject include investigator determine abnormality clinically significant . 4 . Anticipated use study period , use within follow period prior enrollment : 1 . Investigational malaria vaccine within last five year 2 . Chronic systemic immunosuppressive medication ( e.g. , cytotoxic medication , oral/parental corticosteroid &gt; 0.5 mg/kg/day prednisone equivalent ) . Corticosteroid nasal spray allergic rhinitis topical corticosteroid mild , uncomplicated dermatitis allow . 3 . Recurrent receipt blood product immunoglobulins 5 . History : 1 . Sickle cell disease 2 . Splenectomy functional asplenia 3 . Systemic anaphylaxis 4 . Uncontrolled psoriasis porphyria 6 . Clinically significant medical condition , physical examination finding , clinically significant abnormal laboratory result , past medical history may clinically significant implication current health status participation study opinion Investigator . A clinically significant condition process include limit : 1 . A process would affect immune response , require medication affect immune response . 2 . Any contraindication repeat phlebotomy . 7 . History known active cardiac disease include : 1. prior myocardial infarction ( heart attack ) 2. angina pectoris 3. congestive heart failure 4. valvular heart disease 5. cardiomyopathy 6. pericarditis 7. stroke transient ischemic attack 8. exertional chest pain shortness breath 9. heart condition care doctor 8 . Infection HIV , hepatitis B , and/or hepatitis C 9 . Psychiatric condition precludes compliance protocol include limited : 1 . Psychosis within past 3 year 2 . Ongoing risk suicide , history suicide attempt gesture within past 3 year 10 . Suspected known current alcohol drug abuse define American Psychiatric Association Diagnostic Statistical Manual Mental Disorders , Fifth Edition discretion PI 11 . Any finding , judgment Investigator , would interfere , serve contraindication , protocol adherence , assessment safety reactogenicity , subject ability give inform consent , increase risk adverse outcome participating study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 3, 2017</verification_date>
	<keyword>Subjects</keyword>
	<keyword>Venipuncture</keyword>
	<keyword>Research</keyword>
	<keyword>Evaluate</keyword>
	<keyword>Recruit</keyword>
</DOC>